Turning Point Therapeutics Announces Management Transition

    NEXT STORY
    AzurRx BioPharma To Present Interim Phase 2 Clinical Study Data for MS1819-SD, in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency, at Biotech Showcase 2020 Conference (January 13) in San Francisco
    PREV STORY
    T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Analysis on the World’s $13.9 Billion Medical Robotics Market, 2019 to 2026

    author_avatar
    NASDAQ Market News

    Roche reports very strong sales growth in the first nine months of 2019 – outlook raised

    author_avatar
    NASDAQ Market News

    Alcon announces EU launch of CyPass® Micro-Stent, a micro invasive glaucoma surgical device, to lower intraocular pressure (IOP) in patients with primary open-angle glaucoma

    Now available in the UK, Germany, Italy and Spain, CyPass Micro-Stent is designed to ...

    author_avatar
    NASDAQ Market News